Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
0.00 (0.00%)
Aug 7, 2026, 4:00 PM EST

Revium Rx. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2009
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
Revenue
-----0.66
Revenue Growth
------77.96%
Gross Profit
-----0.1
Operating Income
-3.47-3.46-3.57-1-1.19-0.1
Net Income
-13.54-13.45-3.51--1.21-0.1
Earnings Per Share
-0.22-0.22-0.14--0.04-1.78
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2009
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
Cash & Investments
2.142.715.281.190.430
Total Debt
0.150.10-00.2
Net Cash (Debt)
1.992.615.281.190.43-0.2
Net Cash Growth
-59.70%-50.57%342.41%180.71%--
Net Cash Per Share
0.030.040.210.040.02-3.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2009
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
Operating Cash Flow
-2.72-2.53-1.21-1.01-0.823.23
Capital Expenditures
-0.01-0.01-0-0-0-
Free Cash Flow
-2.72-2.54-1.21-1.02-0.823.23
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2009
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
Gross Margin
-----15.59%
Operating Margin
------15.79%
Pretax Margin
------15.79%
Profit Margin
------15.79%
FCF Margin
-----491.85%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2009
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
P/FCF Ratio
-----0.22
PS Ratio
-----1.08